Delcath Systems to Host Quarterly Update Conference Call
21 January 2009 - 5:44AM
PR Newswire (US)
NEW YORK, Jan. 20 /PRNewswire-FirstCall/ -- Delcath Systems, Inc.
(NASDAQ: DCTH) will host its quarterly update conference call at
4:30 PM Eastern Time on Thursday, January 22, 2009. Richard Taney,
President and Chief Executive Officer of Delcath Systems, will host
the call. (Logo:
http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) To
participate in the call, interested parties may dial (888) 790-3326
(U.S./Canada) and use Conference Password: Delcath. The call will
be archived and made available on the Company's website,
http://www.delcath.com/. About Delcath Systems, Inc. Delcath
Systems, Inc. is a medical technology company specializing in
cancer treatment. The Company is testing a proprietary, patented
drug delivery system for the treatment of liver cancers. Delcath's
novel drug delivery platform is testing the delivery of ultra-high
doses of anti-cancer drugs to the liver while preventing these high
doses of drug from entering the patient's bloodstream. The Company
is currently enrolling patients in Phase III and Phase II clinical
studies for the treatment of liver cancers using high doses of
melphalan. The Company's intellectual property portfolio consists
of twenty-eight patents on a worldwide basis including the U.S.,
Europe, Asia and Canada. For more information, please visit the
Company's website at http://www.delcath.com/. The Private
Securities Litigation Reform Act of 1995 provides a safe harbor for
forward-looking statements made by the Company or on its behalf.
This news release contains forward-looking statements, which are
subject to certain risks and uncertainties that can cause actual
results to differ materially from those described. Factors that may
cause such differences include, but are not limited to,
uncertainties relating to our ability to successfully complete
Phase III clinical trials and secure regulatory approval of our
current or future drug-delivery system and uncertainties regarding
our ability to obtain financial and other resources for any
research, development and commercialization activities. These
factors, and others, are discussed from time to time in our filings
with the Securities and Exchange Commission. You should not place
undue reliance on these forward-looking statements, which speak
only as of the date they are made. We undertake no obligation to
publicly update or revise these forward-looking statements to
reflect events or circumstances after the date they are made.
http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO
http://photoarchive.ap.org/ DATASOURCE: Delcath Systems, Inc.
CONTACT: Richard Taney, Delcath Systems, Inc., +1-212-489-2100, ;
or Public Relations: Robin Wagge, Rubenstein Associates, Inc.,
+1-212-843-8006, Web Site: http://www.delcath.com/
Copyright